North America And Europe Preclinical Medical Device Testing Services Market To Reach $3.14 Billion By 2030

North America And Europe Preclinical Medical Device Testing Service Market Growth & Trends

The North America and Europe preclinical medical device testing services market size is expected to reach USD 3.14 billion by 2030, expanding at a CAGR of 9.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increase in the number of small medical devices lacking in-house testing capabilities and complexity in product design are the major factors driving the growth of the market.

There has been an increase in the number of players operating in the market over the last decade. Due to this large number, it has witnessed fierce competition. To sustain the market, a mix of defensive and offensive marketing strategies is used. For instance, extensive R&D, competitive pricing, new product launches, collaborative development, regional expansion, and mergers and acquisitions.

The COVID-19 pandemic has created a huge demand for these services. The rise was not significant in the first half, but it became more significant in the second as the industry adapted to operating during the pandemic. There has been an increase in the production and testing of personal protective equipment, and several projects that were put on hold because of COVID have resumed personal protective equipment. The epidemic has increased demand for a wide range of medical gadgets, diverting attention from those needed for surgery. COVID-19 vaccinations, ventilators, and pulse oximeters are the main goods seeing an increase in demand.

 Request a free sample copy or view the report summary: North America And Europe Preclinical Medical Device Testing Services Market Report

North America And Europe Preclinical Medical Device Testing Services Market Highlights

• In 2024, the biocompatibility tests segment dominated the market, accounting for a revenue share of 44.7%. Manufacturing safe and effective goods is a top priority for medical device manufacturers, and quality assurance is crucial in accomplishing this aim.

• The chemistry test segment is expected to rise with the fastest CAGR of 9.6% in the forecast period. Chemistry tests support the medical device industry across the value chain.

• North America preclinical medical device testing services market dominated in 2024 with a larger share of 55.0%.

North America And Europe Preclinical Medical Device Testing Services Market Segmentation

Grand View Research has segmented the North America and Europe preclinical medical device testing services market on the basis of service and region:

North America And Europe Preclinical Medical Device Testing Services Service Outlook (Revenue, USD Million, 2018 - 2030)

• Biocompatibility Tests

• Chemistry Test

• Microbiology & Sterility Testing

  • Bioburden Determination

  • Pyrogen & Endotoxin Testing

  • Sterility Test and Validation

    • Ethylene Oxide (EO) gas sterilization                                    

    • Gamma-irradiation                                              

    • E-beam sterilization                                      

    • X-ray sterilization

  • Antimicrobial Activity Testing

  • Others

• Package Validation

North America And Europe Preclinical Medical Device Testing Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

List of Key Players of North America And Europe Preclinical Medical Device Testing Services Market

• SGS SA

• Toxikon, Inc.

• Eurofins Scientific

• Pace Analytical Services LLC

• Intertek Group Plc

• WUXI APPTEC

• TÜV SÜD AG

• Sterigenics International LLC

• Nelson Labs

• North American Science Associates, Inc.

• American Preclinical Services

• Charles River Laboratories International, Inc.